AMGEN INC

AMGN · Large cap · 0 articles

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$36.8B	$33.4B	$28.2B	$26.3B	$26.0B
Cost of revenue	$12.0B	$12.9B	$8.5B	$6.4B	$6.5B
Selling, general & administrative	$7.0B	$7.1B	$6.2B	$5.4B	$5.4B
Research and development	$7.3B	$6.0B	$4.8B	$4.4B	$4.8B
Operating income	$9.1B	$7.3B	$7.9B	$9.6B	$7.6B
Pretax income	$9.0B	$4.6B	$7.9B	$7.3B	$6.7B
Income tax expense	$1.3B	$519.0M	$1.1B	$794.0M	$808.0M
Net income	$7.7B	$4.1B	$6.7B	$6.6B	$5.9B
Balance Sheet
Cash and equivalents	$9.1B	$12.0B	$10.9B	$7.6B	$8.0B
Current assets	$29.1B	$29.0B	$30.3B	$22.2B	$19.4B
Total assets	$90.6B	$91.8B	$97.2B	$65.1B	$61.2B
Current liabilities	$25.5B	$23.1B	$18.4B	$15.7B	$12.2B
Stockholders' equity	$8.7B	$5.9B	$6.2B	$3.7B	$6.7B
Cash Flow Statement
Cash from operations	$10.0B	$11.5B	$8.5B	$9.7B	$9.3B
Depreciation and amortization	$5.2B	$5.6B	$4.1B	$3.4B	$3.4B
Stock-based compensation	$494.0M	$530.0M	$431.0M	$401.0M	$341.0M
Capital expenditure	$1.9B	$1.1B	$1.1B	$936.0M	$880.0M
Free cash flow	$8.1B	$10.4B	$7.4B	$8.8B	$8.4B
Dividends paid	$5.1B	$4.8B	$4.6B	$4.2B	$4.0B
Share repurchases	$0	$200.0M	$0	$6.4B	$5.0B
Impairments	$1.2B	—	—	—	—

Shares outstanding 539.7M · Free float 99.8%

Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.